DND PharmaTech Inc
KOSDAQ:347850
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
KR |
|
C
|
Consolidated Construction Consortium Ltd
NSE:CCCL
|
IN |
|
A
|
Ault Alliance Inc
AMEX:AULT
|
US |
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
|
A
|
Acom Co Ltd
F:AK5
|
JP |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
US |
|
C
|
Cargotec Corp
OTC:CYJBF
|
FI |
|
M
|
Marvel Discovery Corp
XBER:O4T
|
CA |
|
Moncler SpA
OTC:MONRF
|
IT |
|
Selfwealth Ltd
ASX:SWF
|
AU |
|
S
|
Sacks Parente Golf Inc
NASDAQ:SPGC
|
US |
|
RealReal Inc
NASDAQ:REAL
|
US |
|
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT
OTC:PPLFF
|
ID |
|
WeTrade Group Inc
NASDAQ:NXTT
|
CN |
|
Cisarua Mountain Dairy Tbk PT
IDX:CMRY
|
ID |
|
Global Capital Markets Ltd
BSE:530263
|
IN |
Shareholder Yield
Current shareholder yield for DND PharmaTech Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
DND PharmaTech Inc
| Average Annual Return | 34.52% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -47% |
| Market Capitalization | 4T KRW |
| Shares Outstanding | 43 800 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
DND PharmaTech Inc's latest stock split occurred on Nov 13, 2025
The company executed a 4-for-1 stock split, meaning that for every share held, investors received 4 new shares.
Before the split, DND PharmaTech Inc traded at 298500 per share. Afterward, the share price was about 81800.
The adjusted shares began trading on Nov 13, 2025. This was the only stock split in DND PharmaTech Inc's history.
